AQUARO, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 17.744
EU - Europa 2.061
AS - Asia 1.436
SA - Sud America 280
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 21.564
Nazione #
US - Stati Uniti d'America 17.701
SG - Singapore 674
RU - Federazione Russa 366
CN - Cina 323
DE - Germania 303
SE - Svezia 294
BR - Brasile 238
UA - Ucraina 224
HK - Hong Kong 187
IT - Italia 178
IE - Irlanda 166
FR - Francia 129
GB - Regno Unito 122
PL - Polonia 109
VN - Vietnam 65
FI - Finlandia 58
KR - Corea 49
BE - Belgio 41
IN - India 30
CA - Canada 29
JP - Giappone 22
AR - Argentina 20
ZA - Sudafrica 20
CZ - Repubblica Ceca 19
NL - Olanda 17
ID - Indonesia 14
BD - Bangladesh 12
TR - Turchia 12
ES - Italia 10
AT - Austria 9
EC - Ecuador 7
IQ - Iraq 7
MX - Messico 7
LT - Lituania 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
MY - Malesia 5
PK - Pakistan 5
AU - Australia 4
CO - Colombia 4
RO - Romania 4
EU - Europa 3
IR - Iran 3
KG - Kirghizistan 3
MA - Marocco 3
OM - Oman 3
PY - Paraguay 3
CI - Costa d'Avorio 2
EG - Egitto 2
GH - Ghana 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
NI - Nicaragua 2
PE - Perù 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
GI - Gibilterra 1
GR - Grecia 1
GT - Guatemala 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
MD - Moldavia 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
SC - Seychelles 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 21.564
Città #
Woodbridge 4.841
Wilmington 4.540
Houston 4.030
Ann Arbor 631
Fairfield 479
Chandler 418
Singapore 359
Ashburn 311
Dallas 283
Moscow 252
Seattle 217
Jacksonville 208
Hong Kong 187
Cambridge 158
Dublin 153
Beijing 140
Medford 111
Kraków 92
Dearborn 79
Santa Clara 75
New York 61
Rome 54
Lawrence 53
The Dalles 53
Los Angeles 51
Brussels 41
Council Bluffs 40
Buffalo 36
Mülheim 36
São Paulo 32
Boardman 30
Menlo Park 29
Munich 28
Zhengzhou 22
Milan 21
Hanoi 20
North Bergen 20
Palo Alto 20
Guangzhou 19
San Diego 19
Ho Chi Minh City 16
Tokyo 15
Orem 14
Warsaw 14
Columbus 13
Redwood City 13
Chicago 12
Olomouc 12
Phoenix 12
Brooklyn 11
Jakarta 11
Kunming 11
London 11
Marseille 11
Norwalk 11
Poplar 11
San Mateo 11
Denver 10
Johannesburg 10
Toronto 10
Amsterdam 9
Chennai 9
Mountain View 9
Bengaluru 8
Hefei 8
Redondo Beach 8
San Francisco 8
Shanghai 8
Stockholm 8
West Jordan 8
Detroit 7
Dong Ket 7
Helsinki 7
Jinan 7
Nanjing 7
Nuremberg 7
University Park 7
Verona 7
Atlanta 6
Boston 6
Brno 6
Lappeenranta 6
Montreal 6
Ankara 5
Curitiba 5
Falls Church 5
Haiphong 5
Modena 5
Rio de Janeiro 5
Seoul 5
Auburn Hills 4
Brasília 4
Changsha 4
Hebei 4
Kilburn 4
Kuala Lumpur 4
Manaus 4
Vienna 4
Washington 4
Andover 3
Totale 18.731
Nome #
1,2,3-TRIAZOLE-[2',5'-BIS-O-(TERT-BUTYLDIMETHYLSILYL)-BETA-D-RIBOFURANOSYL]-3'-SPIRO-5''-(4''-AMINO-1'',2''-OXATHIOL 2'',2''-DIOXIDE) (TSAO) ANALOGS - SYNTHESIS AND ANTI-HIV-1 ACTIVITY 1.046
Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev 497
Therapeutic strategies towards HIV-1 infection in macrophages 489
Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4(+) T lymphocytes 486
Comparative antiviral activity of integrase inhibitors in human monocyte-derived macrophages and lymphocytes 475
Thymosin α 1 potentiates the release by CD8(+) cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro 467
Activity of the (R)-Enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine against human immunodeficiency virus in different human cell systems 465
Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection 463
Understanding HIV compartments and reservoirs 462
Antifungal activity of Cardiospermum halicacabum L. (Sapindaceae) against Trichophyton rubrum occurs through molecular interaction with fungal Hsp90 462
Influenza virus A (H5N1): A pandemic risk? 458
Effect of maraviroc on non-R5 tropic HIV-1: Refined analysis of subjects from the phase IIb study A4001029 456
Potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines 453
Human immunodeficiency virus infection and acquired immunodeficiency syndrome dementia complex: Role of cells of monocyte-macrophage lineage 453
HIV-1-associated dementia during HAART therapy 453
Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure 448
Primary macrophages infected by human immunodeficiency virus trigger CD95-mediated apoptosis of uninfected astrocytes 447
Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: New therapeutic strategies 447
Telomerase activity, hTERT expression, and phosphorylation are downregulated in CD4(+) T lymphocytes infected with human immunodeficiency virus type 1 (HIV-1) 437
Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin 432
Antiviral profile of HIV inhibitors in macrophages: Implications for therapy 432
Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment 424
Natural polymorphisms of HIV-1 subtype-C integrase coding region in a large group of ARV-naïve infected individuals 422
The contribution of peroxynitrite generation in HIV replication in human primary macrophages 417
Novel in vivo model for the study of human immunodeficiency virus type 1 transcription inhibitors: Evaluation of new 6-desfluoroquinolone derivatives 416
gp41 sequence variability in HIV type 1 non-B subtypes infected patients undergoing enfuvirtide pressure 415
Apoptosis and telomeres shortening related to HIV-1 induced oxidative stress in an astrocytoma cell line 411
Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo 405
Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives 404
Specific VpU codon changes were significantly associated with gp120 V3 tropic signatures in HIV-1 B-subtype 401
Limited development and progression of resistance of HIV-1 to the nucleoside analogue reverse transcriptase inhibitor lamivudine in human primary macrophages 400
In vitro activity of inhibitors of late stages of the replication of HIV in chronically infected macrophages 399
The contribution of oxidative stress in apoptosis of human-cultured astroglial cells induced by supernatants of HIV-1-infected macrophages 399
HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro 397
Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors 392
Does residual virus replication during successful HAART lead to HIV-1 genetic evolution? 391
The role of HIV infection in neurologic injury 391
HIV infection in macrophage: role of long-lived cells and related therapeutical strategies 388
Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages 387
Antiretrovirus activity of a novel class of acyclic pyrimidine nucleoside phosphonates 383
Selected nucleotide sequence of the pol gene of the monocytotropic strain HIV type 1 BaL 383
NeuroAIDS: virological aspects of HIV infection 380
Identification of the novel KI polyomavirus in paranasal and lung tissues 363
Profound anti-HIV-1 activity of DAPTA in monocytes/macrophages and inhibition of CCR5-mediated apoptosis in neuronal cells 343
CCR5/CXCR4 dual antagonism for the improvement of HIV infection therapy 339
Effects of amprenavir on HIV-1 maturation, production and infectivity following drug withdrawal in chronically-infected monocytes/macrophages 319
Different kinetics of viral replication and DNA integration in the main HIV-1 cellular reservoirs in the presence and absence of integrase inhibitors 277
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro 235
Antimicrobial properties of the medicinal plant Cardiospermum halicacabum L: New evidence and future perspectives 227
Different patterns of HIV-1 replication in MACROPHAGES is led by co-receptor usage 205
Identification of gp120 polymorphisms in HIV-1 B subtype potentially associated with resistance to fostemsavir 184
The degree of HIV-1 amino acid variability is strictly related to different disease progression rates 173
Phosphatidylcholine Liposomes Down-Modulate CD4 Expression Reducing HIV Entry in Human Type-1 Macrophages 83
Crucial Role of Central Nervous System as a Viral Anatomical Compartment for HIV-1 Infection 66
Evaluation of Natural and Vaccine-Induced Anti-SARS-CoV-2 Immunity: A Comparative Study between Different Groups of Volunteers 59
New Therapies and Strategies to Curb HIV Infections with a Focus on Macrophages and Reservoirs 55
POTENT ANTIVIRAL ACTIVITY OF NEW GENERATION HIV-1 MATURATION INHIBITORS ON HUMAN PRIMARY CELLS 54
Mechanisms underlying of antiretroviral drugs in different cellular reservoirs with a focus on macrophages 48
Inhibition of the Protease of Human Immunodeficiency Virus Blocks Replication and Infectivity of the Virus in Chronically Infected Macrophages 38
Totale 21.701
Categoria #
all - tutte 46.279
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.279


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.400 0 0 0 0 0 312 475 312 67 67 109 58
2021/2022729 30 49 87 52 20 75 29 28 79 91 29 160
2022/20231.060 94 87 11 163 88 211 63 63 101 4 65 110
2023/2024434 60 142 19 9 41 55 14 17 4 12 4 57
2024/20251.436 58 288 154 97 55 144 131 107 168 81 95 58
2025/20261.392 205 162 499 254 238 34 0 0 0 0 0 0
Totale 21.701